Q2 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript
Good afternoon, and welcome, everybody, to this first half results vital meeting which will start in a moment. This is Javier Lopez-Belmonte, Rovi's Vice President and Chief Financial Officer. Please let me introduce Rovi's attendees today, Juan Lopez-Belmonte, Chairman and CEO; Marta Campos, Head of Investor Relations; and myself.
At the end of the presentation, a question-and-answer session will commence. If you want to ask any questions during the presentation, please do not hesitate to send them through the question button on the platform. Thank you for your presence here today. And let's now start the presentation. I Mr. Juan Lopez-Belmonte the floor.
Thank you, Javier, and welcome to everybody. I'm happy to present our first half 2022 results. In these exceptional times, robust performance during the period has been
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |